Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.80 -0.10 (-3.45%)
As of: Sep 30, 2026 · 10:17 AM EDT

Kalaris Therapeutics (KLRS) Operating Expenses (2019 - 2026)

Updated

Kalaris Therapeutics (KLRS) recorded Operating Expenses of $12.39 million in Q2 2026, up 1.1% from $12.26 million a year earlier and up 4.7% from the prior quarter.

Analysis

Kalaris Therapeutics (KLRS) Operating Expenses (2019 - 2026) Analysis & Trends

On a TTM basis, Kalaris Therapeutics' Operating Expenses came in at $47.76 million as of Jun 30, 2026, down 29.3% year-over-year; for FY2025, it was $46.15 million, down 10.8% from FY2024.

  • Annual Operating Expenses has a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
  • Across earlier years, Operating Expenses came in at $51.73 million in FY2024 (-74.1%), $199.9 million in FY2023 (+16.8%), $171.2 million in FY2022 (+0.8%) and $169.82 million in FY2021 (+138.1%).
  • Quarterly Operating Expenses has ranged from $2.56 million in Q1 2024 to $62.41 million in Q4 2023 over the past five years.
  • On a year-over-year basis, Operating Expenses has increased for three consecutive quarters, with growth averaging 48.6% over the last eight quarters.
  • Peak year-over-year performance for Operating Expenses in the last five years was growth of 304.0% in Q1 2025, against a decline of 94.1% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $11.83 million (Q1 2026), $10.8 million (Q4 2025) and $12.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Kalaris Therapeutics 67.84 Mn 67.84 Mn - 12.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.39 Mn
Mar 31, 2026 11.83 Mn
Dec 31, 2025 10.80 Mn
Sep 30, 2025 12.74 Mn
Jun 30, 2025 12.26 Mn
Mar 31, 2025 10.35 Mn
Dec 31, 2024 7.13 Mn
Sep 30, 2024 37.85 Mn
Jun 30, 2024 4.19 Mn
Mar 31, 2024 2.56 Mn
Dec 31, 2023 62.41 Mn
Sep 30, 2023 46.96 Mn
Jun 30, 2023 47.30 Mn
Mar 31, 2023 43.23 Mn
Dec 31, 2022 40.43 Mn
Sep 30, 2022 42.95 Mn
Jun 30, 2022 44.62 Mn
Mar 31, 2022 43.19 Mn
Dec 31, 2021 55.80 Mn
Sep 30, 2021 45.50 Mn
API Access

Kalaris Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=KLRS&period=max&api_key=YOUR_API_KEY